Path180: a computer-based skills program to help teens reduce alcohol use

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adolescents aged 13 to 19 with DSM-5 alcohol use disorder who are receiving mental health counseling or outpatient treatment will be randomized to standard treatment alone or standard treatment plus Path180. The study uses ecological momentary assessment to monitor how Path180 affects the use of cognitive-behavioral skills in real time and consequent alcohol-related outcomes. Path180 provides engaging, evidence-based digital content aimed at reducing alcohol use among youth. The trial seeks to determine acceptability, feasibility, and potential effectiveness of the digital intervention in a real-world clinical setting. The research is conducted at Brown University with NIAAA collaboration, focusing on underserved youth in the early stages of alcohol use disorder.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Ages 13 to 19 years, inclusive; we will exclude children \< 13 due to diversity across adolescence and youths \> 19 because our focus is teenagers
* Seeking/receiving mental health counseling and/or outpatient substance use disorder treatment at Bradley Hospital or another national clinic/treatment service
* Self-reported alcohol use in the past year
* Meets criteria for a current DSM-5 alcohol use disorder assessed using the Schedule for Affective Disorders and Schizophrenia for School-Age Children: Present and Lifetime Version (K-SADS)
* Able to understand written and oral instructions in English, communicate understanding of the consent/assent form, and provide written informed consent/assent
* Complete all assessments required at screening.
* Provide contact information of someone, such as a parent or other family member, who may be able to contact the participant in case of a missed study appointment or follow-up assessment.
* Agree to the schedule of visits, verbally acknowledge that he/she/they will be able to attend each scheduled visit, participate in phone visits and that he/she/they does not have any already scheduled events or a job that may substantially interfere with study participation.
* If younger than 18 years, permission from the minor's legal authorized representative (e.g., caregiver, parent) is required, herein referred to as parent permission.

Exclusion Criteria:

* Current significant alcohol withdrawal symptoms (score \> 10) on the Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-AR); those with current significant alcohol withdrawal may be re-screened after stabilization
* DSM-5 criteria for a severe SUD besides alcohol, cannabis and tobacco
* Psychosis NOTE: Prospective participants diagnosed with psychiatric disorders not specifically excluded above may be included at the discretion of the principal investigator as long as the concurrent treatment for the comorbid psychiatric condition does not compromise the study integrity by virtue of its type, duration, or intensity.

Where it's running

• Brown University Center for Alcohol and Addiction Studies
  Providence, Rhode Island, United States Recruiting

Study contacts

• Study coordinator: Robert Miranda, PhD
• Email: Robert_Miranda_Jr@brown.edu
• Phone: 401-863-6658

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures

  This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.

  Recruiting Université Catholique de Louvain · Brussels, Belgium · NCT07925281

• Thiamine to reduce brain injury in adults with alcohol use disorder

  This trial tests whether thiamine can help protect the brain in adults with moderate to severe alcohol use disorder who drink daily.

  Recruiting Phase 2 Institut National de la Santé Et de la Recherche Médicale, France · Paris, Île-de-France Region · NCT07844720

• Digital Recovery Support for Black adults with Alcohol Use Disorder in Detroit

  This study tests whether a smartphone-based digital recovery program helps Black or African American adults in Detroit maintain their recovery from alcohol use disorder.

  Recruiting Brandeis University · Detroit, Michigan · NCT07724275

• Effects of comorbidity on people with severe mental illness

  This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.

  Recruiting Abant Izzet Baysal University · Bolu, Bolu · NCT07692984

• Psilocybin in Alcohol Use Disorder with Depression (Relapse Prevention)

  This study tests whether higher-dose psilocybin-assisted psychotherapy helps prevent relapse in adults with severe alcohol use disorder and depressive symptoms after detox.

  Recruiting Phase 3 Centre Hospitalier Universitaire de Nīmes · Bayonne and 7 other locations · NCT07638553

• Liver health check plus brief alcohol support for hospitalized adults

  In hospitalized adults who drink harmfully, doctors will test liver stiffness and offer personalized brief alcohol advice to see if it helps reduce drinking compared with usual care.

  Recruiting Oslo University Hospital · Bergen and 7 other locations · NCT07637539

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.